{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:12:51Z","timestamp":1790745171030,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006510","name":"ARSLA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006510","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Neurodis"},{"name":"AFM"},{"name":"CNRS"},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010115","name":"R\u00e9gion Auvergne-Rh\u00f4ne-Alpes","doi-asserted-by":"crossref","award":["ARC2"],"award-info":[{"award-number":["ARC2"]}],"id":[{"id":"10.13039\/501100010115","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00018-019-03059-8","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T10:03:04Z","timestamp":1552384984000},"page":"2615-2632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models"],"prefix":"10.1007","volume":"76","author":[{"given":"Laurent","family":"Coudert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilien","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-5880","authenticated-orcid":false,"given":"Pascal","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"4","key":"3059_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11(4):301\u2013307. \n                    https:\/\/doi.org\/10.1038\/nrm2873","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"3059_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","volume":"33","author":"M Goedert","year":"2010","unstructured":"Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33(7):317\u2013325. \n                    https:\/\/doi.org\/10.1016\/j.tins.2010.04.003","journal-title":"Trends Neurosci"},{"issue":"11","key":"3059_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11910-014-0495-z","volume":"14","author":"M Goedert","year":"2014","unstructured":"Goedert M, Falcon B, Clavaguera F, Tolnay M (2014) Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies. Curr Neurol Neurosci Rep 14(11):495. \n                    https:\/\/doi.org\/10.1007\/s11910-014-0495-z","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3059_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.nbd.2015.02.009","volume":"77","author":"LI Grad","year":"2015","unstructured":"Grad LI, Fernando SM, Cashman NR (2015) From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis. Neurobiol Dis 77:257\u2013265. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2015.02.009","journal-title":"Neurobiol Dis"},{"issue":"7465","key":"3059_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501(7465):45\u201351. \n                    https:\/\/doi.org\/10.1038\/nature12481","journal-title":"Nature"},{"issue":"3","key":"3059_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79(3):416\u2013438. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033","journal-title":"Neuron"},{"issue":"3","key":"3059_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00401-013-1232-4","volume":"127","author":"IR Mackenzie","year":"2014","unstructured":"Mackenzie IR, Frick P, Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127(3):347\u2013357. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1232-4","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3059_CR8","doi-asserted-by":"publisher","first-page":"a024463","DOI":"10.1101\/cshperspect.a024463","volume":"8","author":"T Nonaka","year":"2018","unstructured":"Nonaka T, Hasegawa M (2018) TDP-43 prions. Cold Spring Harb Perspect Med 8(3):a024463. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a024463","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3059_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","volume":"47","author":"SB Prusiner","year":"2013","unstructured":"Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601\u2013623. \n                    https:\/\/doi.org\/10.1146\/annurev-genet-110711-155524","journal-title":"Annu Rev Genet"},{"issue":"3","key":"3059_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.patbio.2014.01.003","volume":"62","author":"M Renner","year":"2014","unstructured":"Renner M, Melki R (2014) Protein aggregation and prionopathies. Pathol Biol (Paris) 62(3):162\u2013168. \n                    https:\/\/doi.org\/10.1016\/j.patbio.2014.01.003","journal-title":"Pathol Biol (Paris)"},{"issue":"10","key":"3059_CR11","doi-asserted-by":"publisher","first-page":"a024141","DOI":"10.1101\/cshperspect.a024141","volume":"9","author":"C Sibilla","year":"2017","unstructured":"Sibilla C, Bertolotti A (2017) Prion properties of SOD1 in amyotrophic lateral sclerosis and potential therapy. Cold Spring Harb Perspect Biol 9(10):a024141. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a024141","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3059_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2823-y","author":"D Vilette","year":"2018","unstructured":"Vilette D, Courte J, Peyrin JM, Coudert L, Schaeffer L, Andreoletti O, Leblanc P (2018) Cellular mechanisms responsible for cell-to-cell spreading of prions. Cell Mol Life Sci. \n                    https:\/\/doi.org\/10.1007\/s00018-018-2823-y","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"3059_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093","journal-title":"Biochem Biophys Res Commun"},{"issue":"5796","key":"3059_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133. \n                    https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"issue":"2","key":"3059_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0385-z","volume":"116","author":"Y Nishihira","year":"2008","unstructured":"Nishihira Y, Tan CF, Onodera O, Toyoshima Y, Yamada M, Morita T, Nishizawa M, Kakita A, Takahashi H (2008) Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 116(2):169\u2013182. \n                    https:\/\/doi.org\/10.1007\/s00401-008-0385-z","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3059_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21154","volume":"61","author":"C Amador-Ortiz","year":"2007","unstructured":"Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease. Ann Neurol 61(5):435\u2013445. \n                    https:\/\/doi.org\/10.1002\/ana.21154","journal-title":"Ann Neurol"},{"issue":"1","key":"3059_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-007-0257-y","volume":"115","author":"F Geser","year":"2008","unstructured":"Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, Igaz LM, Garruto RM, Perl DP, Galasko D, Lee VM, Trojanowski JQ (2008) Pathological TDP-43 in parkinsonism\u2013dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115(1):133\u2013145. \n                    https:\/\/doi.org\/10.1007\/s00401-007-0257-y","journal-title":"Acta Neuropathol"},{"issue":"Pt 5","key":"3059_CR18","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/brain\/awm065","volume":"130","author":"M Hasegawa","year":"2007","unstructured":"Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, Yamazaki M, Oyanagi K (2007) TDP-43 is deposited in the Guam parkinsonism\u2013dementia complex brains. Brain 130(Pt 5):1386\u20131394. \n                    https:\/\/doi.org\/10.1093\/brain\/awm065","journal-title":"Brain"},{"key":"3059_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Kosaka K, Arai H (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res 1184:284\u2013294. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2007.09.048","journal-title":"Brain Res"},{"issue":"3","key":"3059_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114(3):221\u2013229. \n                    https:\/\/doi.org\/10.1007\/s00401-007-0261-2","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3059_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/neup.12427","volume":"38","author":"T Nonaka","year":"2018","unstructured":"Nonaka T, Masuda-Suzukake M, Hasegawa M (2018) Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases. Neuropathology 38(1):64\u201371. \n                    https:\/\/doi.org\/10.1111\/neup.12427","journal-title":"Neuropathology"},{"issue":"7","key":"3059_CR22","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141(7):2181\u20132193. \n                    https:\/\/doi.org\/10.1093\/brain\/awy146","journal-title":"Brain"},{"issue":"6","key":"3059_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67(6):555\u2013564. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e31817713b5","journal-title":"J Neuropathol Exp Neurol"},{"key":"3059_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1872-5","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Corrada MM, Kovacs GG, Dominique M, Caswell C, Xie SX, Lee VM, Kawas CH, Trojanowski JQ (2018) Non-Alzheimer\u2019s contributions to dementia and cognitive resilience in the 90 + study. Acta Neuropathol. \n                    https:\/\/doi.org\/10.1007\/s00401-018-1872-5","journal-title":"Acta Neuropathol"},{"issue":"6375","key":"3059_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1126\/science.aao4426","volume":"359","author":"MA Lodato","year":"2018","unstructured":"Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M, Sherman MA, Vitzthum CM, Luquette LJ, Yandava CN, Yang P, Chittenden TW, Hatem NE, Ryu SC, Woodworth MB, Park PJ, Walsh CA (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359(6375):555\u2013559. \n                    https:\/\/doi.org\/10.1126\/science.aao4426","journal-title":"Science"},{"issue":"12","key":"3059_CR26","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/nm.4001","volume":"21","author":"S Kaushik","year":"2015","unstructured":"Kaushik S, Cuervo AM (2015) Proteostasis and aging. Nat Med 21(12):1406\u20131415. \n                    https:\/\/doi.org\/10.1038\/nm.4001","journal-title":"Nat Med"},{"issue":"4","key":"3059_CR27","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3892\/etm.2016.3566","volume":"12","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Chen WW, Zhang X (2016) Huntington\u2019s disease: molecular basis of pathology and status of current therapeutic approaches. Exp Ther Med 12(4):1951\u20131956. \n                    https:\/\/doi.org\/10.3892\/etm.2016.3566","journal-title":"Exp Ther Med"},{"issue":"1","key":"3059_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. \n                    https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"2","key":"3059_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrd1077","volume":"1","author":"JF Gusella","year":"2000","unstructured":"Gusella JF, MacDonald ME (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 1(2):109\u2013115. \n                    https:\/\/doi.org\/10.1038\/nrd1077","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"3059_CR30","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology. Proc Natl Acad Sci USA 96(8):4604\u20134609","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3059_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12426","volume":"26","author":"U Rub","year":"2016","unstructured":"Rub U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW (2016) Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol 26(6):726\u2013740. \n                    https:\/\/doi.org\/10.1111\/bpa.12426","journal-title":"Brain Pathol"},{"issue":"1","key":"3059_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20121898","volume":"452","author":"M Costanzo","year":"2013","unstructured":"Costanzo M, Zurzolo C (2013) The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. Biochem J 452(1):1\u201317. \n                    https:\/\/doi.org\/10.1042\/BJ20121898","journal-title":"Biochem J"},{"key":"3059_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fnins.2017.00647","volume":"11","author":"M Masnata","year":"2017","unstructured":"Masnata M, Cicchetti F (2017) The evidence for the spread and seeding capacities of the mutant huntingtin protein in in vitro systems and their therapeutic implications. Front Neurosci 11:647. \n                    https:\/\/doi.org\/10.3389\/fnins.2017.00647","journal-title":"Front Neurosci"},{"issue":"12","key":"3059_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 67(12):1159\u20131165. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e31818e8951","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"3059_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","volume":"124","author":"M Tada","year":"2012","unstructured":"Tada M, Coon EA, Osmand AP, Kirby PA, Martin W, Wieler M, Shiga A, Shirasaki H, Makifuchi T, Yamada M, Kakita A, Nishizawa M, Takahashi H, Paulson HL (2012) Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol 124(5):749\u2013760. \n                    https:\/\/doi.org\/10.1007\/s00401-012-1005-5","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3059_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","volume":"135","author":"I St-Amour","year":"2018","unstructured":"St-Amour I, Turgeon A, Goupil C, Planel E, Hebert SS (2018) Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease. Acta Neuropathol 135(2):249\u2013265. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1786-7","journal-title":"Acta Neuropathol"},{"issue":"34","key":"3059_CR37","doi-asserted-by":"publisher","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","volume":"285","author":"RA Fuentealba","year":"2010","unstructured":"Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, Diamond MI, Weihl CC, Baloh RH (2010) Interaction with polyglutamine aggregates reveals a Q\/N-rich domain in TDP-43. J Biol Chem 285(34):26304\u201326314. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.125039","journal-title":"J Biol Chem"},{"issue":"3","key":"3059_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10571-016-0350-7","volume":"36","author":"X Zhang","year":"2016","unstructured":"Zhang X, Abels ER, Redzic JS, Margulis J, Finkbeiner S, Breakefield XO (2016) Potential transfer of polyglutamine and CAG-repeat RNA in extracellular vesicles in Huntington\u2019s disease: background and evaluation in cell culture. Cell Mol Neurobiol 36(3):459\u2013470. \n                    https:\/\/doi.org\/10.1007\/s10571-016-0350-7","journal-title":"Cell Mol Neurobiol"},{"issue":"7010","key":"3059_CR39","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431(7010):805\u2013810. \n                    https:\/\/doi.org\/10.1038\/nature02998","journal-title":"Nature"},{"issue":"31","key":"3059_CR40","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","volume":"30","author":"J Miller","year":"2010","unstructured":"Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, Finkbeiner S (2010) Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into Huntington\u2019s disease molecular pathogenesis. J Neurosci 30(31):10541\u201310550. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0146-10.2010","journal-title":"J Neurosci"},{"issue":"8","key":"3059_CR41","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00018-011-0879-z","volume":"69","author":"S Alais","year":"2012","unstructured":"Alais S, Soto-Rifo R, Balter V, Gruffat H, Manet E, Schaeffer L, Darlix JL, Cimarelli A, Raposo G, Ohlmann T, Leblanc P (2012) Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties. Cell Mol Life Sci 69(8):1331\u20131352. \n                    https:\/\/doi.org\/10.1007\/s00018-011-0879-z","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"3059_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.febslet.2008.12.031","volume":"583","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Arai T, Buratti E, Baralle FE, Akiyama H, Hasegawa M (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 583(2):394\u2013400. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2008.12.031","journal-title":"FEBS Lett"},{"issue":"18","key":"3059_CR43","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 18(18):3353\u20133364. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddp275","journal-title":"Hum Mol Genet"},{"issue":"10","key":"3059_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/BC20080025","volume":"100","author":"S Alais","year":"2008","unstructured":"Alais S, Simoes S, Baas D, Lehmann S, Raposo G, Darlix JL, Leblanc P (2008) Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 100(10):603\u2013615. \n                    https:\/\/doi.org\/10.1042\/BC20080025","journal-title":"Biol Cell"},{"issue":"1","key":"3059_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64(1):60\u201370. \n                    https:\/\/doi.org\/10.1002\/ana.21425","journal-title":"Ann Neurol"},{"issue":"19","key":"3059_CR46","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","volume":"582","author":"Y Inukai","year":"2008","unstructured":"Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle FE, Akiyama H, Hisanaga S, Hasegawa M (2008) Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 582(19):2899\u20132904. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2008.07.027","journal-title":"FEBS Lett"},{"issue":"1","key":"3059_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, Yoshida M, Murayama S, Mann DM, Akiyama H, Hasegawa M (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4(1):124\u2013134. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2013.06.007","journal-title":"Cell Rep"},{"key":"3059_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.nbd.2016.08.007","volume":"96","author":"P Smethurst","year":"2016","unstructured":"Smethurst P, Newcombe J, Troakes C, Simone R, Chen YR, Patani R, Sidle K (2016) In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol Dis 96:236\u2013247. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2016.08.007","journal-title":"Neurobiol Dis"},{"issue":"Pt 15","key":"3059_CR49","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1242\/jcs.004598","volume":"120","author":"KJ Lee","year":"2007","unstructured":"Lee KJ, Panzera A, Rogawski D, Greene LE, Eisenberg E (2007) Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation. J Cell Sci 120(Pt 15):2663\u20132671. \n                    https:\/\/doi.org\/10.1242\/jcs.004598","journal-title":"J Cell Sci"},{"issue":"1","key":"3059_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/neup.12053","volume":"34","author":"Y Toyoshima","year":"2014","unstructured":"Toyoshima Y, Takahashi H (2014) TDP-43 pathology in polyglutamine diseases: with reference to amyotrophic lateral sclerosis. Neuropathology 34(1):77\u201382. \n                    https:\/\/doi.org\/10.1111\/neup.12053","journal-title":"Neuropathology"},{"issue":"17","key":"3059_CR51","doi-asserted-by":"publisher","first-page":"8896","DOI":"10.1074\/jbc.M115.713552","volume":"291","author":"S Shimonaka","year":"2016","unstructured":"Shimonaka S, Nonaka T, Suzuki G, Hisanaga S, Hasegawa M (2016) Templated aggregation of TAR DNA-binding protein of 43\u00a0kDa (TDP-43) by seeding with TDP-43 peptide fibrils. J Biol Chem 291(17):8896\u20138907. \n                    https:\/\/doi.org\/10.1074\/jbc.M115.713552","journal-title":"J Biol Chem"},{"issue":"7650","key":"3059_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, Messing J, Kim HJ, Soriano A, Auburger G, Pulst SM, Taylor JP, Rigo F, Gitler AD (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544(7650):367\u2013371. \n                    https:\/\/doi.org\/10.1038\/nature22038","journal-title":"Nature"},{"issue":"7310","key":"3059_CR53","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069\u20131075. \n                    https:\/\/doi.org\/10.1038\/nature09320","journal-title":"Nature"},{"issue":"27","key":"3059_CR54","doi-asserted-by":"publisher","first-page":"9133","DOI":"10.1523\/JNEUROSCI.0996-12.2012","volume":"32","author":"MP Hart","year":"2012","unstructured":"Hart MP, Gitler AD (2012) ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci 32(27):9133\u20139142. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0996-12.2012","journal-title":"J Neurosci"},{"issue":"3","key":"3059_CR55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00401-011-0862-7","volume":"122","author":"Y Toyoshima","year":"2011","unstructured":"Toyoshima Y, Tanaka H, Shimohata M, Kimura K, Morita T, Kakita A, Takahashi H (2011) Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol 122(3):375\u2013378. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0862-7","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3059_CR56","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12031-011-9548-9","volume":"45","author":"NM Bonini","year":"2011","unstructured":"Bonini NM, Gitler AD (2011) Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS. J Mol Neurosci 45(3):676\u2013683. \n                    https:\/\/doi.org\/10.1007\/s12031-011-9548-9","journal-title":"J Mol Neurosci"},{"issue":"6","key":"3059_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/bpa.12427","volume":"26","author":"E Marti","year":"2016","unstructured":"Marti E (2016) RNA toxicity induced by expanded CAG repeats in Huntington\u2019s disease. Brain Pathol 26(6):779\u2013786. \n                    https:\/\/doi.org\/10.1111\/bpa.12427","journal-title":"Brain Pathol"},{"issue":"1","key":"3059_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JHD-150177","volume":"5","author":"BP Culver","year":"2016","unstructured":"Culver BP, DeClercq J, Dolgalev I, Yu MS, Ma B, Heguy A, Tanese N (2016) Huntington\u2019s disease protein huntingtin associates with its own mRNA. J Huntingtons Dis 5(1):39\u201351. \n                    https:\/\/doi.org\/10.3233\/JHD-150177","journal-title":"J Huntingtons Dis"},{"issue":"11","key":"3059_CR59","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1074\/jbc.M115.695379","volume":"291","author":"T Nonaka","year":"2016","unstructured":"Nonaka T, Suzuki G, Tanaka Y, Kametani F, Hirai S, Okado H, Miyashita T, Saitoe M, Akiyama H, Masai H, Hasegawa M (2016) Phosphorylation of TAR DNA-binding protein of 43\u00a0kDa (TDP-43) by truncated casein kinase 1delta triggers mislocalization and accumulation of TDP-43. J Biol Chem 291(11):5473\u20135483. \n                    https:\/\/doi.org\/10.1074\/jbc.M115.695379","journal-title":"J Biol Chem"},{"key":"3059_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy174","author":"T Nonaka","year":"2018","unstructured":"Nonaka T, Masuda-Suzukake M, Hosokawa M, Shimozawa A, Hirai S, Okado H, Hasegawa M (2018) C9ORF72 dipeptide repeat poly-GA inclusions promote: intracellular aggregation of phosphorylated TDP-43. Hum Mol Genet. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddy174","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3059_CR61","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, Lee EB, Trojanowski JQ, Lee VM (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 9(1):4220. \n                    https:\/\/doi.org\/10.1038\/s41467-018-06548-9","journal-title":"Nat Commun"},{"issue":"1","key":"3059_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.febslet.2011.11.019","volume":"586","author":"F Herrera","year":"2012","unstructured":"Herrera F, Outeiro TF (2012) alpha-Synuclein modifies huntingtin aggregation in living cells. FEBS Lett 586(1):7\u201312. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2011.11.019","journal-title":"FEBS Lett"},{"issue":"33","key":"3059_CR63","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1073\/pnas.1412504111","volume":"111","author":"C Kayatekin","year":"2014","unstructured":"Kayatekin C, Matlack KE, Hesse WR, Guan Y, Chakrabortee S, Russ J, Wanker EE, Shah JV, Lindquist S (2014) Prion-like proteins sequester and suppress the toxicity of huntingtin exon 1. Proc Natl Acad Sci USA 111(33):12085\u201312090. \n                    https:\/\/doi.org\/10.1073\/pnas.1412504111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"3059_CR64","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/hmg\/ddu606","volume":"24","author":"GM Pocas","year":"2015","unstructured":"Pocas GM, Branco-Santos J, Herrera F, Outeiro TF, Domingos PM (2015) alpha-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila. Hum Mol Genet 24(7):1898\u20131907. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu606","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3059_CR65","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/hmg\/dds485","volume":"22","author":"A Tauffenberger","year":"2013","unstructured":"Tauffenberger A, Chitramuthu BP, Bateman A, Bennett HP, Parker JA (2013) Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington\u2019s disease models. Hum Mol Genet 22(4):782\u2013794. \n                    https:\/\/doi.org\/10.1093\/hmg\/dds485","journal-title":"Hum Mol Genet"},{"issue":"8","key":"3059_CR66","doi-asserted-by":"publisher","first-page":"e1006563","DOI":"10.1371\/journal.ppat.1006563","volume":"13","author":"E Katorcha","year":"2017","unstructured":"Katorcha E, Makarava N, Lee YJ, Lindberg I, Monteiro MJ, Kovacs GG, Baskakov IV (2017) Cross-seeding of prions by aggregated alpha-synuclein leads to transmissible spongiform encephalopathy. PLoS Pathog 13(8):e1006563. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1006563","journal-title":"PLoS Pathog"},{"issue":"35","key":"3059_CR67","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1073\/pnas.0404968101","volume":"101","author":"IL Derkatch","year":"2004","unstructured":"Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW (2004) Effects of Q\/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 101(35):12934\u201312939. \n                    https:\/\/doi.org\/10.1073\/pnas.0404968101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3059_CR68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/hmg\/ddr507","volume":"21","author":"C Tomas-Zapico","year":"2012","unstructured":"Tomas-Zapico C, Diez-Zaera M, Ferrer I, Gomez-Ramos P, Moran MA, Miras-Portugal MT, Diaz-Hernandez M, Lucas JJ (2012) alpha-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington\u2019s disease. Hum Mol Genet 21(3):495\u2013510. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddr507","journal-title":"Hum Mol Genet"},{"key":"3059_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2012.02.032","volume":"1462","author":"CM Dewey","year":"2012","unstructured":"Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G (2012) TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res 1462:16\u201325. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2012.02.032","journal-title":"Brain Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03059-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:24:04Z","timestamp":1583871844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":69,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03059-8","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Experiments described in this manuscript comply with the current laws of the country.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}